Literature DB >> 35920977

Vineland Adaptive Behavior Scale in a Cohort of Four ADNP Syndrome Patients Implicates Age-Dependent Developmental Delays with Increased Impact of Activities of Daily Living.

Joseph Levine1,2, Fahed Hakim3, R Frank Kooy4, Illana Gozes5.   

Abstract

Activity-dependent neuroprotective protein (ADNP) is one of the lead genes in autism spectrum disorder/intellectual disability. Heterozygous, de novo ADNP mutations cause the ADNP syndrome. Here, to evaluate natural history of the syndrome, mothers of two ADNP syndrome boys aged 6 and a half and two adults aged 27 years (man and woman) were subjected to Vineland III questionnaire assessing adaptive behavior. The boys were assessed again about 2 years after the first measurements. The skill measures, presented as standard scores (SS) included domains of communication, daily living, socialization, motor skills and a sum of adaptive behavior composite. The age equivalent (AE) and growth scale values (GSV) encompassing 11 subdomains assess the age level at which the subject's raw score is found at a norm sample median and the individual temporal progression, respectively. The norm referenced standard scores age-matched, mean 100 ± 15 of the two children showed the lowest outcome in communication (SS: 20-30). Daily living skills presented SS of 50-60, with a possible potential loss of some activities as the child ages, especially in interpersonal relationships with people outside of the immediate family (boy A). In contrast, in socialization, both children were at the SS of 38, with some positive increase to SS of ~ 45 (interpersonal relations with family members and coping skills, depending on the particular individual), 2 years later. Interestingly, there was an apparent large difference in motor skills (gross and fine) at the young age, with subject B showing a relatively higher level of skills (SS: 70), decreasing to subject A level (SS: 40) 2 years later. Together, the adaptive behavior composite suggested a level of SS: 39-48 with B showing a potential increase (SS: 41-44) and A, a substantial decrease (SS: 48-39), suggesting a strong impact of daily living skills. Adults were at SS: 20, which is the lowest possible score. AE showed minor improvements for subject A and B, with all AE values being below 3 years. GSVs for subject A showed some improvement with age, especially in interpersonal, play and leisure, and gross motor subdomains. GSV for subject B showed minor improvements in the various subdomains. Notably, all subjects showed a percentile rank < 1 compared with age-matched norms except for subject B as to motor domain (2nd percentile) at the age of 6 years. In summary, the results, especially comparing SS and AEs between childhood and adulthood, implied a continuous deterioration of activities compared to the general population, encompassing a slower developmental process coupled to possible neurodegeneration, strongly supporting a great need for disease modifying medicinal procedures.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ADNP syndrome (Helsmoortel Van Der Aa syndrome); Age equivalent [AE]; Growth scale values [GSV]; Natural history; Vineland Adaptive Behavior Scales (VABS); Vineland III (Vineland-3); Vineland standard scores [SS]

Mesh:

Substances:

Year:  2022        PMID: 35920977     DOI: 10.1007/s12031-022-02048-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   2.866


  76 in total

1.  Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.

Authors:  M Bassan; R Zamostiano; A Davidson; A Pinhasov; E Giladi; O Perl; H Bassan; C Blat; G Gibney; G Glazner; D E Brenneman; I Gozes
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

2.  Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.

Authors:  N Amram; G Hacohen-Kleiman; S Sragovich; A Malishkevich; J Katz; O Touloumi; R Lagoudaki; N C Grigoriadis; E Giladi; A Yeheskel; M Pasmanik-Chor; Y Jouroukhin; I Gozes
Journal:  Mol Psychiatry       Date:  2016-01-19       Impact factor: 15.992

3.  In vivo and in vitro ketamine exposure exhibits a dose-dependent induction of activity-dependent neuroprotective protein in rat neurons.

Authors:  B P Brown; S C Kang; K Gawelek; R A Zacharias; S R Anderson; C P Turner; J K Morris
Journal:  Neuroscience       Date:  2015-01-13       Impact factor: 3.590

4.  Ketamine administration in early postnatal life as a tool for mimicking Autism Spectrum Disorders core symptoms.

Authors:  Maria Bove; Stefania Schiavone; Paolo Tucci; Vladyslav Sikora; Stefania Dimonte; Anna Laura Colia; Maria Grazia Morgese; Luigia Trabace
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2022-04-20       Impact factor: 5.067

5.  Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia.

Authors:  Axel Becker; Brigitte Peters; Helmut Schroeder; Tobias Mann; Gerald Huether; Gisela Grecksch
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-06       Impact factor: 5.067

Review 6.  PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Giuseppe Musumeci; Dora Reglodi; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

7.  Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome.

Authors:  Eric G Bend; Erfan Aref-Eshghi; David B Everman; R Curtis Rogers; Sara S Cathey; Eloise J Prijoles; Michael J Lyons; Heather Davis; Katie Clarkson; Karen W Gripp; Dong Li; Elizabeth Bhoj; Elaine Zackai; Paul Mark; Hakon Hakonarson; Laurie A Demmer; Michael A Levy; Jennifer Kerkhof; Alan Stuart; David Rodenhiser; Michael J Friez; Roger E Stevenson; Charles E Schwartz; Bekim Sadikovic
Journal:  Clin Epigenetics       Date:  2019-04-27       Impact factor: 6.551

8.  Whole genome sequencing of 45 Japanese patients with intellectual disability.

Authors:  Chihiro Abe-Hatano; Aritoshi Iida; Shunichi Kosugi; Yukihide Momozawa; Chikashi Terao; Keiko Ishikawa; Mariko Okubo; Yasuo Hachiya; Hiroya Nishida; Kazuyuki Nakamura; Rie Miyata; Chie Murakami; Kan Takahashi; Kyoko Hoshino; Haruko Sakamoto; Sayaka Ohta; Masaya Kubota; Eri Takeshita; Akihiko Ishiyama; Eiji Nakagawa; Masayuki Sasaki; Mitsuhiro Kato; Naomichi Matsumoto; Yoichiro Kamatani; Michiaki Kubo; Yoshiyuki Takahashi; Jun Natsume; Ken Inoue; Yu-Ichi Goto
Journal:  Am J Med Genet A       Date:  2021-02-24       Impact factor: 2.802

9.  Episignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype.

Authors:  Michael S Breen; Paras Garg; Lara Tang; Danielle Mendonca; Tess Levy; Mafalda Barbosa; Anne B Arnett; Evangeline Kurtz-Nelson; Emanuele Agolini; Agatino Battaglia; Andreas G Chiocchetti; Christine M Freitag; Alicia Garcia-Alcon; Paola Grammatico; Irva Hertz-Picciotto; Yunin Ludena-Rodriguez; Carmen Moreno; Antonio Novelli; Mara Parellada; Giulia Pascolini; Flora Tassone; Dorothy E Grice; Daniele Di Marino; Raphael A Bernier; Alexander Kolevzon; Andrew J Sharp; Joseph D Buxbaum; Paige M Siper; Silvia De Rubeis
Journal:  Am J Hum Genet       Date:  2020-08-05       Impact factor: 11.043

View more
  1 in total

1.  Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk.

Authors:  Maram Ganaiem; Gidon Karmon; Yanina Ivashko-Pachima; Illana Gozes
Journal:  Cells       Date:  2022-09-26       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.